A genome-wide association and fine-mapping study of Samoans led to a missense mutation in the CREBRF gene that seems to correspond with increased fat storage.
The firm is investing in studies that use its multiplex microarray platform to monitor lupus disease activity and traumatic brain injury response.
The Finnish firm is hoping to finalize manufacturing, validation, and commercialization of its new sample-to-result infectious disease diagnostics platform.
The firm is developing tests based on its microarray technology, which is capable of printing multiple types of biomarkers.
The company is targeting the new product at researchers who need a comprehensive, pan-ethnic, and affordable solution to genotype many samples.
In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.
Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.
Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.
A new report indicates that women are underrepresented among US patent holders.